Sensei biotherapeutics to host virtual key opinion leader event, “a new vista for cancer care: exploring sns-101's potential as a transformative treatment option for patients with solid tumors”

- featuring dr. james gulley, co-director of the center for immuno-oncology at the national cancer institute (nci) and internationally recognized expert on cancer immunotherapy -
SNSE Ratings Summary
SNSE Quant Ranking